
Articles
-
Jul 31, 2023 |
mivision.com.au | Michelle Hauschild
Dr Fabrizio has 15 years’ experience in the public health sector, including a decade in the eye health sector with experience in the strategic development, promotion, and advocacy of policy positions relating to eye health. His career encompasses roles working with governments, non-government organisations, the World Health Organization, academia, and the private sector. Dr Fabrizio has 15 years’ experience in the public health sector, including a decade in the eye health sector
-
Jul 27, 2023 |
mivision.com.au | Michelle Hauschild
Sponsored by Vision Hospital Group the free webinar has been accredited for 1.5 CPD hours. The event will commence with a presentation on glaucoma by Dr Jason Cheng. With two fellowships and a wealth of experience in this subspecialty, Dr Cheng will provide advice on streamlining diagnosis, progression analysis and referral letters in routine open-angle glaucoma.
-
Jul 3, 2023 |
mivision.com.au | Michelle Hauschild
FHD-286 is an enzymatic inhibitor of BRG1 and BRM, two proteins that promote cancer cell growth. According to news reports, the company said data released from a dose-escalation study in metastatic uveal melanoma showed that the drug “reinforces the safety and tolerability profile” of the candidate but will not be pursued further in this indication. The trial assessed 73 patients with the retinal tumour who received one of nine different regimens, including one of four different FHD-286 doses.
-
May 31, 2023 |
mivision.com.au | Michelle Hauschild
Not surprising then, that the number of people suffering from dry eye is increasing. Many people put up with the debilitating symptoms of dry eye: the dry, gritty burning sensation, the redness, the watery or teary eyes, or the blurry eyes – often without recognising that there is treatment available. Intense Regulated Pulsed LightDry eye has traditionally been treated with drops, lid massage, warm compresses, and manual expression.
-
May 8, 2023 |
mivision.com.au | Michelle Hauschild
Authors of the study, published in JAMA Internal Medicine, said further trials might show that using artificial intelligence (AI) to answer patient queries might “improve responses, lower clinician burnout, and improve patient outcomes”.1The researchers selected 195 exchanges from a publicly accessible social media forum. They used the original full text of a patient’s question to generate a new chatbot session and compared the responses of the physician and the chatbot.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →